过氧症可以通过通过mTOR途径促进AECII自和亡来诱导肺损伤
Yingcong Ren1, Song Qin1, Xinxin Liu1
1Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou, China.
Molecular biotechnology
|November 8, 2023
概括
过氧导致急性肺损伤通过激活mTOR介导的膜细胞的自. 抑制mTOR会使损伤恶化,而激活它会减少损伤,揭示了肺部疾病的关键途径.
科学领域:
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
- 疾病的分子机制.
背景情况:
- 氧气治疗至关重要,但可能导致肺损伤 (过氧性急性肺损伤,HALI).
- 该mTOR途径调节细胞生存,自和细胞亡,与疾病相关的过程.
- 在HALI中mTOR通路的作用仍然不清楚.
研究的目的:
- 阐明涉及mTOR通路的HALI分子机制.
- 研究mTOR调制对高氧化引起的肺损伤的影响.
主要方法:
- 建立了体外 (用H2O2处理的MLE-12细胞) 和体内 (暴露于过氧的老鼠) 模型.
- 使用了西式涂抹,自标签,TUNEL和HE染色.
- 使用的mTOR抑制剂 (拉巴胺素) 和激活剂 (MHY1485).
主要成果:
- 过氧和H2O2诱导了膜细胞和肺组织中的自和亡.
- mTOR抑制 (拉巴胺) 加剧过氧/H2O2诱导的自,亡和肺损伤.
- mTOR激活 (MHY1485) 抑制了自,减少了亡和肺损伤.
结论:
- 过氧症通过在膜上皮细胞中通过mTOR介导的自引发急性肺损伤.
- 针对mTOR途径为HALI提供了一个潜在的治疗策略.
相关概念视频
Acute Respiratory Failure-II
249
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
249
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Electron Transport Chain: Complex I and II
14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.2K


